<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34659245</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.</ArticleTitle><Pagination><StartPage>748097</StartPage><MedlinePgn>748097</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">748097</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.748097</ELocationID><Abstract><AbstractText>The SARS-CoV-2 infection [coronavirus disease 2019 (COVID-19)] is associated with severe lymphopenia and impaired immune response, including expansion of myeloid cells with regulatory functions, e.g., so-called low-density neutrophils, containing granulocytic myeloid-derived suppressor cells (LDNs/PMN-MDSCs). These cells have been described in both infections and cancer and are known for their immunosuppressive activity. In the case of COVID-19, long-term complications have been frequently observed (long-COVID). In this context, we aimed to investigate the immune response of COVID-19 convalescents after a mild or asymptomatic course of disease. We enrolled 13 convalescents who underwent a mild or asymptomatic infection with SARS-CoV-2, confirmed by a positive result of the PCR test, and 13 healthy donors without SARS-CoV-2 infection in the past. Whole blood was used for T-cell subpopulation and LDNs/PMN-MDSCs analysis. LDNs/PMN-MDSCs and normal density neutrophils (NDNs) were sorted out by FACS and used for T-cell proliferation assay with autologous T cells activated with anti-CD3 mAb. Serum samples were used for the detection of anti-SARS-CoV-2 neutralizing IgG and GM-CSF concentration. Our results showed that in convalescents, even 3 months after infection, an elevated level of LDNs/PMN-MDSCs is still maintained in the blood, which correlates negatively with the level of CD8<sup>+</sup> and double-negative T cells. Moreover, LDNs/PMN-MDSCs and NDNs showed a tendency for affecting the production of anti-SARS-CoV-2 S1 neutralizing antibodies. Surprisingly, our data showed that in addition to LDNs/PMN-MDSCs, NDNs from convalescents also inhibit proliferation of autologous T cells. Additionally, in the convalescent sera, we detected significantly higher concentrations of GM-CSF, indicating the role of emergency granulopoiesis. We conclude that in mild or asymptomatic COVID-19 convalescents, the neutrophil dysfunction, including propagation of PD-L1-positive LDNs/PMN-MDSCs and NDNs, is responsible for long-term endotype of immunosuppression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Siemi&#x144;ska, W&#x119;glarczyk, Surmiak, Kurowska-Baran, Sanak, Siedlar and Baran.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siemi&#x144;ska</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#x119;glarczyk</LastName><ForeName>Kazimierz</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surmiak</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurowska-Baran</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Laboratory of Virology and Serology, University Children's Hospital, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanak</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siedlar</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baran</LastName><ForeName>Jarek</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>83869-56-1</RegistryNumber><NameOfSubstance UI="D016178">Granulocyte-Macrophage Colony-Stimulating Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058345" MajorTopicYN="N">Asymptomatic Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016178" MajorTopicYN="N">Granulocyte-Macrophage Colony-Stimulating Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072737" MajorTopicYN="N">Myeloid-Derived Suppressor Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 convalescents</Keyword><Keyword MajorTopicYN="N">granulocyte-macrophage colony stimulating factor (GM-CSF)</Keyword><Keyword MajorTopicYN="N">granulocytic myeloid-derived suppressor cells (PMN-MDSCs)</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">low-density neutrophils (LDNs)</Keyword><Keyword MajorTopicYN="N">normal density neutrophils</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>18</Day><Hour>8</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34659245</ArticleId><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.748097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B, Guo H, Zhou P, Shi Z&#x2013;L. Characteristics of SARS&#x2013;CoV&#x2013;2 and COVID&#x2013;19. Nat Rev Microbiol 2020 19:3 (2020) 19:141&#x2013;54. doi:&#xa0;10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Gao Y, Shi S, Chen Y, Yang K, Tian J. Drinking No&#x2013;Links to the Severity of COVID&#x2013;19: A Systematic Review and Meta&#x2013;Analysis: Drinking and COVID&#x2013;19. J Infect (2020) 81:e126&#x2013;7. doi:&#xa0;10.1016/j.jinf.2020.05.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7255718</ArticleId><ArticleId IdType="pubmed">32474047</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. . Clinical Characteristics of Coronavirus Disease 2019 (COVID&#x2013;19) in China: A Systematic Review and Meta&#x2013;Analysis. J Infect (2020) 80:656&#x2013;65. doi:&#xa0;10.1016/j.jinf.2020.03.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.041</ArticleId><ArticleId IdType="pmc">PMC7151416</ArticleId><ArticleId IdType="pubmed">32283155</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med (2020) 382:1708&#x2013;20. doi:&#xa0;10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID&#x2013;19 in Wuhan, China: A Retrospective Cohort Study. Lancet (2020) 395:1054&#x2013;62. doi:&#xa0;10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, et al. . Lymphopenia Predicts Disease Severity of COVID&#x2013;19: A Descriptive and Predictive Study. Signal Transduction Targeted Ther (2020) 5:1&#x2013;3. doi:&#xa0;10.1038/s41392-020-0148-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0148-4</ArticleId><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, P&#xf6;hlmann S. Human Coronavirus NL63 Employs the Severe Acute Respiratory Syndrome Coronavirus Receptor for Cellular Entry. Proc Natl Acad Sci USA (2005) 102:7988&#x2013;93. doi:&#xa0;10.1073/pnas.0409465102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409465102</ArticleId><ArticleId IdType="pmc">PMC1142358</ArticleId><ArticleId IdType="pubmed">15897467</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS&#x2013;CoV&#x2013;2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues. Infect Dis Poverty (2020) 9:1&#x2013;7. doi:&#xa0;10.1186/s40249-020-00662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpa R, Costa L, del Puente A, Caso F. Role of Thymopoiesis and Inflamm&#x2013;Aging in COVID&#x2013;19 Phenotype. Pediatr Neonatol (2020) 61:364&#x2013;5. doi:&#xa0;10.1016/j.pedneo.2020.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7158784</ArticleId><ArticleId IdType="pubmed">32317217</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, et al. . Significant Changes of Peripheral T Lymphocyte Subsets in Patients With Severe Acute Respiratory Syndrome. J Infect Dis (2004) 189(4):648&#x2013;51. doi:&#xa0;10.1086/381535</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/381535</ArticleId><ArticleId IdType="pmc">PMC7109946</ArticleId><ArticleId IdType="pubmed">14767818</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy KE, Brakenridge SC, Francois B, Daix T, Deutschman CS, Monneret G, et al. . Immunotherapies for COVID&#x2013;19: Lessons Learned From Sepsis. Lancet Respir Med (2020) 8:946. doi:&#xa0;10.1016/S2213-2600(20)30217-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30217-4</ArticleId><ArticleId IdType="pmc">PMC7195015</ArticleId><ArticleId IdType="pubmed">32444269</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. . Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID&#x2013;19). Front Immunol (2020) 11:827. doi:&#xa0;10.3389/fimmu.2020.00827</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. . Elevated Exhaustion Levels and Reduced Functional Diversity of T Cells in Peripheral Blood may Predict Severe Progression in COVID&#x2013;19 Patients. Cell Mol Immunol (2020) 17:541&#x2013;3. doi:&#xa0;10.1038/S41423-020-0401-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41423-020-0401-3</ArticleId><ArticleId IdType="pmc">PMC7091621</ArticleId><ArticleId IdType="pubmed">32203186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. . Functional Exhaustion of Antiviral Lymphocytes in COVID&#x2013;19 Patients. Cell Mol Immunol (2020) 17:533&#x2013;5. doi:&#xa0;10.1038/S41423-020-0402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Chander Chiang K. Prostaglandin D2 as a Mediator of Lymphopenia and a Therapeutic Target in COVID&#x2013;19 Disease. Med Hypotheses (2020) 143:110122. doi:&#xa0;10.1016/j.mehy.2020.110122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110122</ArticleId><ArticleId IdType="pmc">PMC7373045</ArticleId><ArticleId IdType="pubmed">32759007</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabanelli S, Chevalier MF, Martinez&#x2013;Usatorre A, Gomez&#x2013;Cadena A, Salom&#xe9; B, Lecciso M, et al. . Tumour&#x2013;Derived PGD2 and NKp30&#x2013;B7H6 Engagement Drives an Immunosuppressive ILC2&#x2013;MDSC Axis. Nat Commun (2017) 8:1&#x2013;14. doi:&#xa0;10.1038/s41467-017-00678-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00678-2</ArticleId><ArticleId IdType="pmc">PMC5605498</ArticleId><ArticleId IdType="pubmed">28928446</ArticleId></ArticleIdList></Reference><Reference><Citation>Arocena AR, Onofrio LI, Pellegrini AV, Silva AEC, Paroli A, Cano RC, et al. . Myeloid&#x2013;Derived Suppressor Cells are Key Players in the Resolution of Inflammation During a Model of Acute Infection. European J Immunol (2014) 44(1):184&#x2013;94. doi:&#xa0;10.1002/eji.201343606</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201343606</ArticleId><ArticleId IdType="pubmed">24166778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi A, Grassi G, Bordoni V, Lorenzini P, Cimini E, Casetti R, et al. . Early Expansion of Myeloid&#x2013;Derived Suppressor Cells Inhibits SARS&#x2013;CoV&#x2013;2 Specific T&#x2013;Cell Response and may Predict Fatal COVID&#x2013;19 Outcome. Cell Death Dis (2020) 11:1&#x2013;9. doi:&#xa0;10.1038/s41419-020-03125-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03125-1</ArticleId><ArticleId IdType="pmc">PMC7590570</ArticleId><ArticleId IdType="pubmed">33110074</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich DI, Nagaraj S. Myeloid&#x2013;Derived&#x2013;Supressor Cells as Regulators of Th Eimmune System. Nat Rev Immunol (2009) 9:162&#x2013;74. doi:&#xa0;10.1038/nri2506.Myeloid-derived-suppressor</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2506.Myeloid-derived-suppressor</ArticleId><ArticleId IdType="pmc">PMC2828349</ArticleId><ArticleId IdType="pubmed">19197294</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich DI, Ostrand&#x2013;Rosenberg S, Bronte V. Coordinated Regulation of Myeloid Cells by Tumours. Nat Rev Immunol (2012) 12:253&#x2013;68. doi:&#xa0;10.1038/nri3175</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3175</ArticleId><ArticleId IdType="pmc">PMC3587148</ArticleId><ArticleId IdType="pubmed">22437938</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor MA, Rastad JL, Green WR. The Role of Myeloid&#x2013;Derived Suppressor Cells in Viral Infection. Viral Immunol (2017) 30:82&#x2013;97. doi:&#xa0;10.1089/vim.2016.0125</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2016.0125</ArticleId><ArticleId IdType="pmc">PMC5346953</ArticleId><ArticleId IdType="pubmed">28051364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren JP, Zhao J, Dai J, Griffin JWD, Wang L, Wu XY, et al. . Hepatitis C Virus&#x2013;Induced Myeloid&#x2013;Derived Suppressor Cells Regulate T&#x2013;Cell Differentiation and Function via the Signal Transducer and Activator of Transcription 3 Pathway. Immunology (2016) 148:377&#x2013;86. doi:&#xa0;10.1111/imm.12616</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12616</ArticleId><ArticleId IdType="pmc">PMC4948036</ArticleId><ArticleId IdType="pubmed">27149428</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowlands M, Segal F, Hartl D. Myeloid&#x2013;Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID&#x2013;19. Front Immunol (2021) 12:697405. doi:&#xa0;10.3389/fimmu.2021.697405</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.697405</ArticleId><ArticleId IdType="pmc">PMC8250151</ArticleId><ArticleId IdType="pubmed">34220859</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassetta L, Bruderek K, Skrzeczynska&#x2013;Moncznik J, Osiecka O, Hu X, Rundgren IM, et al. . Differential Expansion of Circulating Human MDSC Subsets in Patients With Cancer, Infection and Inflammation. J ImmunoTher Cancer (2020) 8:e001223. doi:&#xa0;10.1136/jitc-2020-001223</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-001223</ArticleId><ArticleId IdType="pmc">PMC7481096</ArticleId><ArticleId IdType="pubmed">32907925</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhaven C, van der Bruggen P, Bruger AM. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer. J Clin Med (2021) 10:2872. doi:&#xa0;10.3390/JCM10132872</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM10132872</ArticleId><ArticleId IdType="pmc">PMC8268873</ArticleId><ArticleId IdType="pubmed">34203451</ArticleId></ArticleIdList></Reference><Reference><Citation>Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, et al. . Immunosuppression Mediated by Myeloid&#x2013;Derived Suppressor Cells (MDSCs) During Tumour Progression. Br J Cancer (2019) 120:16&#x2013;25. doi:&#xa0;10.1038/s41416-018-0333-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-018-0333-1</ArticleId><ArticleId IdType="pmc">PMC6325125</ArticleId><ArticleId IdType="pubmed">30413826</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura T, Kambayashi Y, Aiba S. Crosstalk Between Regulatory T Cells (Tregs) and Myeloid Derived Suppressor Cells (MDSCs) During Melanoma Growth. Oncoimmunology (2012) 1:1433&#x2013;4. doi:&#xa0;10.4161/onci.21176</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/onci.21176</ArticleId><ArticleId IdType="pmc">PMC3518528</ArticleId><ArticleId IdType="pubmed">23243619</ArticleId></ArticleIdList></Reference><Reference><Citation>Scapini P, Marini O, Tecchio C, Cassatella MA. Human Neutrophils in the Saga of Cellular Heterogeneity: Insights and Open Questions. Immunol Rev (2016) 273:48&#x2013;60. doi:&#xa0;10.1111/imr.12448</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12448</ArticleId><ArticleId IdType="pubmed">27558327</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestre&#x2013;Roig C, Fridlender ZG, Glogauer M, Scapini P. Neutrophil Diversity in Health and Disease. Trends Immunol (2019) 40(7):565&#x2013;83. doi:&#xa0;10.1016/j.it.2019.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2019.04.012</ArticleId><ArticleId IdType="pmc">PMC7185435</ArticleId><ArticleId IdType="pubmed">31160207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V, Brandau S, Chen S&#x2013;H, Colombo MP, Frey AB, Greten TF, et al. . Recommendations for Myeloid&#x2013;Derived Suppressor Cell Nomenclature and Characterization Standards. Nat Commun (2016) 7:12150. doi:&#xa0;10.1038/ncomms12150</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12150</ArticleId><ArticleId IdType="pmc">PMC4935811</ArticleId><ArticleId IdType="pubmed">27381735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegde S, Leader AM, Merad M. MDSC: Markers, Development, States, and Unaddressed Complexity. Immunity (2021) 54:875&#x2013;84. doi:&#xa0;10.1016/J.IMMUNI.2021.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMMUNI.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8709560</ArticleId><ArticleId IdType="pubmed">33979585</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitte J, Diallo AB, Boumaza A, Lopez A, Michel M, Allardet&#x2013;Servent J, et al. . A Granulocytic Signature Identifies COVID&#x2013;19 and Its Severity. J Infect Dis (2020) 222:1985&#x2013;96. doi:&#xa0;10.1093/INFDIS/JIAA591</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAA591</ArticleId><ArticleId IdType="pmc">PMC7543529</ArticleId><ArticleId IdType="pubmed">32941618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean MJ, Ochoa JB, Sanchez&#x2013;Pino M, Zabaleta J, Garai J, del Valle L, et al. . Transcriptome and Functions of Granulocytic Myeloid&#x2013;Derived Suppressor Cells Determine Their Association With Disease Severity of COVID&#x2013;19. medRxiv (2021) 2021.03.26.21254441. doi:&#xa0;10.1101/2021.03.26.21254441</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.26.21254441</ArticleId></ArticleIdList></Reference><Reference><Citation>Takano T, Matsumura T, Adachi Y, Terahara K, Moriyama S, Onodera T, et al. . Myeloid Cell Dynamics Correlating With Clinical Outcomes of Severe COVID&#x2013;19 in Japan. Int Immunol (2021) 33:241&#x2013;7. doi:&#xa0;10.1093/intimm/dxab005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxab005</ArticleId><ArticleId IdType="pmc">PMC7928855</ArticleId><ArticleId IdType="pubmed">33538817</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte&#x2013;Schrepping J, Reusch N, Paclik D, Saliba A&#x2013;E, Sander LE, Ba&#xdf;ler K, et al. . Severe COVID&#x2013;19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell (2020) 182:1419&#x2013;40. doi:&#xa0;10.1016/j.cell.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck&#x2013;Jones S, Vangeti S, Yu M, Falck&#x2013;Jones R, Cagigi A, Badolati I, et al. . Functional Monocytic Myeloid&#x2013;Derived Suppressor Cells Increase in Blood But Not Airways and Predict COVID&#x2013;19 Severity. J Clin Invest (2021) 131:e144734. doi:&#xa0;10.1172/JCI144734</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI144734</ArticleId><ArticleId IdType="pmc">PMC7954608</ArticleId><ArticleId IdType="pubmed">33492309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomi&#x107; S, &#x110;oki&#x107; J, Stevanovi&#x107; D, Ili&#x107; N, Gruden&#x2013;Movsesijan A, Dini&#x107; M, et al. . Reduced Expression of Autophagy Markers and Expansion of Myeloid&#x2013;Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID&#x2013;19 Patients. Front Immunol (2021) 12:614599. doi:&#xa0;10.3389/fimmu.2021.614599</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.614599</ArticleId><ArticleId IdType="pmc">PMC7937809</ArticleId><ArticleId IdType="pubmed">33692788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaravaradan V, Mir KD, Sodora DL. Double&#x2013;Negative T Cells During HIV/SIV Infections: Potential Pinch Hitters in the T&#x2013;Cell Lineup. Curr Opin HIV AIDS (2012) 7:164&#x2013;71. doi:&#xa0;10.1097/COH.0b013e3283504a66</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0b013e3283504a66</ArticleId><ArticleId IdType="pmc">PMC3639317</ArticleId><ArticleId IdType="pubmed">22241163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, To KK&#x2013;W, Wong Y&#x2013;C, Liu L, Zhou B, Li X, et al. . Acute SARS&#x2013;CoV&#x2013;2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity (2020) 53:864. doi:&#xa0;10.1016/J.IMMUNI.2020.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMMUNI.2020.07.026</ArticleId><ArticleId IdType="pmc">PMC7402670</ArticleId><ArticleId IdType="pubmed">32791036</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna S, Graef S, Mussai F, Thomas A, Wali N, Yenidunya BG, et al. . Tumor&#x2013;Derived GM&#x2013;CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clin Cancer Res (2018) 24:2859&#x2013;72. doi:&#xa0;10.1158/1078-0432.CCR-17-3757</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-17-3757</ArticleId><ArticleId IdType="pmc">PMC6601632</ArticleId><ArticleId IdType="pubmed">29602801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvedaraite E, Hertwig L, Sinha I, Ponzetta A, Hed Myrberg I, Lourda M, et al. . Major Alterations in the Mononuclear Phagocyte Landscape Associated With COVID&#x2013;19 Severity. Proc Natl Acad Sci USA (2021) 118:e2018587118. doi:&#xa0;10.1073/PNAS.2018587118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/PNAS.2018587118</ArticleId><ArticleId IdType="pmc">PMC8017719</ArticleId><ArticleId IdType="pubmed">33479167</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, et al. . Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe From Mild COVID&#x2013;19. Cell (2020) 182:1401&#x2013;1418.e18. doi:&#xa0;10.1016/J.CELL.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Peruzzi B, Bencini S, Capone M, Mazzoni A, Maggi L, Salvati L, et al. . Quantitative and Qualitative Alterations of Circulating Myeloid Cells and Plasmacytoid DC in SARS&#x2013;CoV&#x2013;2 Infection. Immunology (2020) 161:345&#x2013;53. doi:&#xa0;10.1111/IMM.13254</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/IMM.13254</ArticleId><ArticleId IdType="pmc">PMC7692244</ArticleId><ArticleId IdType="pubmed">32870529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Rustagi A, Zhao NQ, Roque J, Mart&#xed;nez&#x2013;Col&#xf3;n GJ, McKechnie JL, et al. . A Single&#x2013;Cell Atlas of the Peripheral Immune Response in Patients With Severe COVID&#x2013;19. Nat Med (2020) 26:1070. doi:&#xa0;10.1038/S41591-020-0944-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-020-0944-Y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos&#x2013;Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. . Complex Immune Dysregulation in COVID&#x2013;19 Patients With Severe Respiratory Failure. Cell Host Microbe (2020) 27:992. doi:&#xa0;10.1016/J.CHOM.2020.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CHOM.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses K, Brandau S. Human Neutrophils: Their Role in Cancer and Relation to Myeloid&#x2013;Derived Suppressor Cells. Semin Immunol (2016) 28:187&#x2013;96. doi:&#xa0;10.1016/j.smim.2016.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2016.03.018</ArticleId><ArticleId IdType="pubmed">27067179</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassetta L, Baekkevold ES, Brandau S, Bujko A, Cassatella MA, Dorhoi A, et al. . Deciphering Myeloid&#x2013;Derived Suppressor Cells: Isolation and Markers in Humans, Mice and Non&#x2013;Human Primates. Cancer Immunol Immunother (2019) 68:687. doi:&#xa0;10.1007/S00262-019-02302-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00262-019-02302-2</ArticleId><ArticleId IdType="pmc">PMC6447515</ArticleId><ArticleId IdType="pubmed">30684003</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarts CEM, Hiemstra IH, B&#xe9;guin EP, Hoogendijk AJ, Bouchmal S, van Houndt M, et al. . Activated Neutrophils Exert Myeloid&#x2013;Derived Suppressor Cell Activity Damaging T Cells Beyond Repair. Blood Adv (2019) 3:3562&#x2013;74. doi:&#xa0;10.1182/BLOODADVANCES.2019031609</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/BLOODADVANCES.2019031609</ArticleId><ArticleId IdType="pmc">PMC6880908</ArticleId><ArticleId IdType="pubmed">31738831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sippel T, White J, Nag K, Tsvankin V, Klaassen M, Kleinschmidt&#x2013;DeMasters, et al. . Neutrophil Degranulation and Immunosuppression in Patients With GBM: Restoration of Cellular Immune Function by Targeting Arginase I. AACR (2011) 17(22):6992&#x2013;7002. doi:&#xa0;10.1158/1078-0432.CCR-11-1107</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-11-1107</ArticleId><ArticleId IdType="pubmed">21948231</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J, Tak T, Kamp VM, Koenderman L. Immune Suppression by Neutrophils and Granulocytic Myeloid&#x2013;Derived Suppressor Cells: Similarities and Differences. Cell Mol Life Sci 2013 70:20 (2013) 70:3813&#x2013;27. doi:&#xa0;10.1007/S00018-013-1286-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00018-013-1286-4</ArticleId><ArticleId IdType="pmc">PMC3781313</ArticleId><ArticleId IdType="pubmed">23423530</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, et al. . Myeloid&#x2013;Derived Suppressor Cells in the Peripheral Blood of Cancer Patients Contain a Subset of Immature Neutrophils With Impaired Migratory Properties. J Leukocyte Biol (2011) 89:311&#x2013;7. doi:&#xa0;10.1189/jlb.0310162</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0310162</ArticleId><ArticleId IdType="pubmed">21106641</ArticleId></ArticleIdList></Reference><Reference><Citation>Janols H, Bergenfelz C, Allaoui R, Larsson A, Ryd&#xe9;n L, Bj&#xf6;rnsson S, et al. . A High Frequency of MDSCs in Sepsis Patients, With the Granulocytic Subtype Dominating in Gram&#x2013;Positive Cases. J Leukocyte Biol (2014) 96:685&#x2013;93. doi:&#xa0;10.1189/jlb.5HI0214-074R</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.5HI0214-074R</ArticleId><ArticleId IdType="pubmed">24929004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagiv JY, Michaeli J, Fridlender ZG, Granot Z, Sagiv JY, Michaeli J, et al. . Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer Article Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer. CellReports (2015) 10:562&#x2013;73. doi:&#xa0;10.1016/j.celrep.2014.12.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.039</ArticleId><ArticleId IdType="pubmed">25620698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, et al. . Arginase I&#x2013;Producing Myeloid&#x2013;Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes. Cancer Res (2009) 69:1553&#x2013;60. doi:&#xa0;10.1158/0008-5472.CAN-08-1921</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-1921</ArticleId><ArticleId IdType="pmc">PMC2900845</ArticleId><ArticleId IdType="pubmed">19201693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. . Arginase&#x2013;Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion. Cancer Res (2005) 65:3044&#x2013;8. doi:&#xa0;10.1158/0008-5472.CAN-04-4505</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-4505</ArticleId><ArticleId IdType="pubmed">15833831</ArticleId></ArticleIdList></Reference><Reference><Citation>Garley M, Jab&#x142;o&#x144;ska E. Heterogeneity Among Neutrophils. Archivum Immunologiae Therapiae Exp (2018) 66:21&#x2013;30. doi:&#xa0;10.1007/s00005-017-0476-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-017-0476-4</ArticleId><ArticleId IdType="pmc">PMC5767199</ArticleId><ArticleId IdType="pubmed">28560557</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Ai Z, Khoyratty T, Zec K, Eames HL, Grinsven Ev, et al. . ROS&#x2013;Producing Immature Neutrophils in Giant Cell Arteritis Are Linked to Vascular Pathologies. JCI Insight (2020) 5:e139163. doi:&#xa0;10.1172/JCI.INSIGHT.139163</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI.INSIGHT.139163</ArticleId><ArticleId IdType="pmc">PMC7605529</ArticleId><ArticleId IdType="pubmed">32960815</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco&#x2013;Camarillo C, Alam&#xe1;n OR, Rosales C. Low&#x2013;Density Neutrophils in Healthy Individuals Display a Mature Primed Phenotype. Front Immunol (2021) 12:2021.672520. doi:&#xa0;10.3389/fimmu.2021.672520</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.672520</ArticleId><ArticleId IdType="pmc">PMC8285102</ArticleId><ArticleId IdType="pubmed">34276661</ArticleId></ArticleIdList></Reference><Reference><Citation>Coudereau R, Waeckel L, Cour M, Rimmele T, Pescarmona R, Fabri A, et al. . Emergence of Immunosuppressive LOX&#x2013;1+ PMN&#x2013;MDSC in Septic Shock and Severe COVID&#x2013;19 Patients With Acute Respiratory Distress Syndrome. J&#xa0;Leukocyte Biol (2021) 28:1&#x2013;8. doi:&#xa0;10.1002/JLB.4COVBCR0321-129R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4COVBCR0321-129R</ArticleId><ArticleId IdType="pmc">PMC8242532</ArticleId><ArticleId IdType="pubmed">33909917</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F, Lesouhaitier M, Gregoire M, Pinceaux K, Gacouin A, Maamar A, et al. . SARS&#x2013;CoV&#x2013;2&#x2013;Induced ARDS Associates With MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage. J Clin Immunol (2021) 41:515&#x2013;25. doi:&#xa0;10.1007/s10875-020-00920-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, et al. . Expansion of Myeloid&#x2013;Derived Suppressor Cells in Patients With Severe Coronavirus Disease (COVID&#x2013;19). Cell Death Differ (2020) 27:3196&#x2013;207. doi:&#xa0;10.1038/s41418-020-0572-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0572-6</ArticleId><ArticleId IdType="pmc">PMC7278239</ArticleId><ArticleId IdType="pubmed">32514047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanseviero E, Kim R, Gabrilovich DI. Isolation and Phenotyping of Splenic Myeloid&#x2013;Derived Suppressor Cells in Murine Cancer Models. In: Methods in Molecular Biology. Humana Press Inc. (2021) p. 19&#x2013;28. doi:&#xa0;10.1007/978-1-0716-1060-2_3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1060-2_3</ArticleId><ArticleId IdType="pubmed">33237537</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. . Deep Immune Profiling of COVID&#x2013;19 Patients Reveals Distinct Immunotypes With Therapeutic Implications. Science (2020) 369:eabc8511. doi:&#xa0;10.1126/SCIENCE.ABC8511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABC8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan F, van den AT, Hussein S, Marcellino BK, Khattar P, Glicksberg BS, et al. . Jamal SM El. Activation of Cytotoxic T Cell Population and Inversion of CD4:CD8 Ratio as Manifestations of Cellular Immune Response in SARS&#x2013;COV&#x2013;2 Infection. J Hematopathol (2020) 13:1. doi:&#xa0;10.1007/S12308-020-00405-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12308-020-00405-9</ArticleId><ArticleId IdType="pmc">PMC7332243</ArticleId><ArticleId IdType="pubmed">32837599</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. . Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. J&#xa0;Clin Invest (2020) 130:2620&#x2013;9. doi:&#xa0;10.1172/JCI137244</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri&#x2013;Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, et al. . Comprehensive Mapping of Immune Perturbations Associated With Severe COVID&#x2013;19. Sci Immunol (2020) 5:eabd7114. doi:&#xa0;10.1126/SCIIMMUNOL.ABD7114</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIIMMUNOL.ABD7114</ArticleId><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. . Impaired Immune Cell Cytotoxicity in Severe COVID&#x2013;19 Is IL&#x2013;6 Dependent. J Clin Invest (2020) 130:4694&#x2013;703. doi:&#xa0;10.1172/JCI138554</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138554</ArticleId><ArticleId IdType="pmc">PMC7456250</ArticleId><ArticleId IdType="pubmed">32463803</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelosanto JM, Wherry EJ. Transcription Factor Regulation of CD8+ T&#x2013;Cell Memory and Exhaustion. Immunol Rev (2010) 236:167&#x2013;75. doi:&#xa0;10.1111/J.1600-065X.2010.00927.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1600-065X.2010.00927.X</ArticleId><ArticleId IdType="pubmed">20636816</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Guo W, Dong Y, Wang X, Dai D, Liu X, et al. . Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID&#x2013;19 Disease. Front Immunol (2020) 11:580237. doi:&#xa0;10.3389/FIMMU.2020.580237</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2020.580237</ArticleId><ArticleId IdType="pmc">PMC7591707</ArticleId><ArticleId IdType="pubmed">33154753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, et al. . PD&#x2013;1&#x2013;Expressing SARS&#x2013;CoV&#x2013;2&#x2013;Specific CD8+ T Cells Are Not Exhausted, But Functional in Patients With COVID&#x2013;19. Immunity (2021) 54:44&#x2013;52.e3. doi:&#xa0;10.1016/j.immuni.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7834198</ArticleId><ArticleId IdType="pubmed">33338412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, et al. . Characteristics of Peripheral Lymphocyte Subset Alteration in COVID&#x2013;19 Pneumonia. J Infect Dis (2020) 221:1762&#x2013;9. doi:&#xa0;10.1093/INFDIS/JIAA150</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAA150</ArticleId><ArticleId IdType="pmc">PMC7184346</ArticleId><ArticleId IdType="pubmed">32227123</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadori A, Zamarchi R, de Silvestro G, Forza G, Cavatton G, Danieli GA, et al. . Genetic Control of the CD4/CD8 T&#x2013;Cell Ratio in Humans. Nat Med (1995) 1:1279&#x2013;83. doi:&#xa0;10.1038/nm1295-1279</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1295-1279</ArticleId><ArticleId IdType="pubmed">7489409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaseen MM, Abuharfeil NM, Darmani H, Daoud A. Mechanisms of Immune Suppression by Myeloid&#x2013;Derived Suppressor Cells: The Role of Interleukin&#x2013;10 as a Key Immunoregulatory Cytokine. Open Biol (2020) 10:200111. doi:&#xa0;10.1098/rsob.200111</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200111</ArticleId><ArticleId IdType="pmc">PMC7536076</ArticleId><ArticleId IdType="pubmed">32931721</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J, Wei X, Qin S, Liu X, Jiang Y, Chen Y, et al. . Continuous Tracking of COVID&#x2013;19 Patients&#x2019; Immune Status. Int Immunopharmacol (2020) 89:107034. doi:&#xa0;10.1016/j.intimp.2020.107034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107034</ArticleId><ArticleId IdType="pmc">PMC7518179</ArticleId><ArticleId IdType="pubmed">33039966</ArticleId></ArticleIdList></Reference><Reference><Citation>Tullio G, Strippoli S, Angarano R, Fazio V, Sgherza N, Negri A, et al. . &#x3b1;&#x3b2;&#x2013;Double Negative CD4/CD8 (CD56) T Cell (DNTs) in Metastatic Melanoma: Basal Frequency and Behaviour During Ipilimumab Treatment. Preliminary Evaluations. J Trans Med (2015) 13:O10. doi:&#xa0;10.1186/1479-5876-13-S1-O10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-13-S1-O10</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahran AM, Zahran ZAM, Mady YH, Mahran EEM, Rashad A, Makbould A, et al. . Differential Alterations in Peripheral Lymphocyte Subsets in COVID&#x2013;19 Patients: Upregulation of Double&#x2013;Positive and Double&#x2013;Negative T Cells. Multidiscip Respir Med (2021) 16. doi:&#xa0;10.4081/mrm.2021.758</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2021.758</ArticleId><ArticleId IdType="pmc">PMC8215531</ArticleId><ArticleId IdType="pubmed">34221400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelis FJN, Jaufmann J, Singh A, Fromm K, Teschner AC, P&#xf6;schel S, et al. . Myeloid&#x2013;Derived Suppressor Cells Modulate B&#x2013;Cell Responses. Immunol Lett (2017) 188:108&#x2013;15. doi:&#xa0;10.1016/J.IMLET.2017.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMLET.2017.07.003</ArticleId><ArticleId IdType="pubmed">28687234</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. . Immunological Memory to SARS&#x2013;CoV&#x2013;2 Assessed for Up to 8 Months After Infection. Science (2021) 371. doi:&#xa0;10.1126/science.abf4063</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano A, Parrinello NL, Simeon V, Puglisi F, la Cava P, Bellofiore C, et al. . High&#x2013;Density Neutrophils in MGUS and Multiple Myeloma Are Dysfunctional and Immune&#x2013;Suppressive Due to Increased STAT3 Downstream Signaling. Sci Rep (2020) 10:1&#x2013;18. doi:&#xa0;10.1038/s41598-020-58859-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58859-x</ArticleId><ArticleId IdType="pmc">PMC7005058</ArticleId><ArticleId IdType="pubmed">32029833</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martinez&#x2013;Col&#xf3;n GJ, et al. . Multi&#x2013;Omic Profiling Reveals Widespread Dysregulation of Innate Immunity and Hematopoiesis in COVID&#x2013;19. J Exp Med (2021) 218(8):e20210582. doi:&#xa0;10.1084/jem.20210582</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210582</ArticleId><ArticleId IdType="pmc">PMC8210586</ArticleId><ArticleId IdType="pubmed">34128959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN, et al. . Longitudinal Immune Profiling Reveals Key Myeloid Signatures Associated With COVID&#x2013;19. Sci Immunol (2020) 15:5(51). doi:&#xa0;10.1126/sciimmunol.eabd6197</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.eabd6197</ArticleId><ArticleId IdType="pmc">PMC7857390</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang CC, Korinek M, Chebg WJ, Hwang TL. Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease. Front Pharmacol (2020) 11:2020.572009. doi:&#xa0;10.3389/fphar.2020.572009</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.572009</ArticleId><ArticleId IdType="pmc">PMC7583590</ArticleId><ArticleId IdType="pubmed">33162887</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschenbrenner AC, Mouktaroudi M, Kr&#xe4;mer B, Oestreich M, Antonakos N, Nuesch&#x2013;Germano M, et al. . Disease Severity&#x2013;Specific Neutrophil Signatures in Blood Transcriptomes Stratify COVID&#x2013;19 Patients. Genome Med (2021) 13:7. doi:&#xa0;10.1186/s13073-020-00823-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-020-00823-5</ArticleId><ArticleId IdType="pmc">PMC7805430</ArticleId><ArticleId IdType="pubmed">33441124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P, de Sanctis F, Can&#xe8; S, Ugel S, Donadello K, Castellucci M, et al. . Deciphering the State of Immune Silence in Fatal COVID&#x2013;19 Patients. Nat Commun (2021) 12:1&#x2013;15. doi:&#xa0;10.1038/s41467-021-21702-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21702-6</ArticleId><ArticleId IdType="pmc">PMC7935849</ArticleId><ArticleId IdType="pubmed">33674591</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, et al. . Mature CD10 + and Immature CD10&#x2013;Neutrophils Present in G&#x2013;CSF&#x2013;Treated Donors Display Opposite Effects on T Cells. Blood (2017) 129(10):1343&#x2013;56. doi:&#xa0;10.1182/blood-2016-04-713206</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-04-713206</ArticleId><ArticleId IdType="pubmed">28053192</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RJ, Justen JM, Sam LM. Recombinant Human Granulocytemacrophage Colony&#x2013;Stimulating Factor Induces Granule Exocytosis From Human Polymorphonuclear Neutrophils. Inflammation (1990) 14:83&#x2013;92. doi:&#xa0;10.1007/BF00914032</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00914032</ArticleId><ArticleId IdType="pubmed">2182533</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2013;Shami A, Mahanna W, Naccache PH. Granulocyte&#x2013;Macrophage Colony&#x2013;Stimulating Factor&#x2013;Activated Signaling Pathways in Human Neutrophils. Selective Activation of Jak2, Stat3, and Stat5B. J Biol Chem (1998) 273:1058&#x2013;63. doi:&#xa0;10.1074/jbc.273.2.1058</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.2.1058</ArticleId><ArticleId IdType="pubmed">9422769</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargett T, Christo SN, Hercus TR, Abbas N, Singhal N, Lopez AF, et al. . GM&#x2013;CSF Signalling Blockade and Chemotherapeutic Agents Act in Concert to Inhibit the Function of Myeloid&#x2013;Derived Suppressor Cells In Vitro . Clin Trans Immunol (2016) 5:e119. doi:&#xa0;10.1038/cti.2016.80</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2016.80</ArticleId><ArticleId IdType="pmc">PMC5192067</ArticleId><ArticleId IdType="pubmed">28090321</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites RS, Uruchurtu ASS, Siggins MK, Liew F, Russell CD, Moore SC, et al. . Inflammatory Profiles Across the Spectrum of Disease Reveal a Distinct Role for GM&#x2013;CSF in Severe COVID&#x2013;19. Sci Immunol (2021) 6:9873. doi:&#xa0;10.1126/SCIIMMUNOL.ABG9873</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIIMMUNOL.ABG9873</ArticleId><ArticleId IdType="pmc">PMC8128298</ArticleId><ArticleId IdType="pubmed">33692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Condamine T, Gabrilovich DI. Molecular Mechanisms Regulating Myeloid&#x2013;Derived Suppressor Cell Differentiation and Function. Trends Immunol (2011) 32:19&#x2013;25. doi:&#xa0;10.1016/J.IT.2010.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IT.2010.10.002</ArticleId><ArticleId IdType="pmc">PMC3053028</ArticleId><ArticleId IdType="pubmed">21067974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C&#x2013;F, Sabath F, Fibi&#x2013;Smetana S, Sun S, &#xd6;llinger R, Noe&#xdf;ner E, et al. . Convalescent COVID&#x2013;19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities. Front Immunol (2021) 0:601080. doi:&#xa0;10.3389/FIMMU.2021.601080</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.601080</ArticleId><ArticleId IdType="pmc">PMC8634761</ArticleId><ArticleId IdType="pubmed">34867933</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>